Safety Evaluation of ART352-L in Patients Undergoing Posterolateral Spinal Fusion

Condition:   Degenerative Spondylolisthesis Intervention:   Biological: ART352-L Sponsor:   Ankasa Regenerative Therapeutics, Inc. Not yet recruiting

Source: ClinicalTrials.gov - May 7, 2020 Category: Research Source Type: clinical trials